Bob Lapetina - 05 Aug 2025 Form 3 Insider Report for CG Oncology, Inc. (CGON)

Role
Interim Principal Financial and Accounting Officer
Signature
/s/ Joshua Patterson, Attorney-in-Fact for Robert Lapetina
Issuer symbol
CGON
Transactions as of
05 Aug 2025
Transactions value $
$0
Form type
3
Filing time
06 Aug 2025, 16:15:04 UTC
Previous filing
04 Jan 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lapetina Bob Interim Principal Financial and Accounting Officer C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE /s/ Joshua Patterson, Attorney-in-Fact for Robert Lapetina 06 Aug 2025 0002006639

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGON Employee Stock Option (Right to Buy) 05 Aug 2025 Common Stock 13K $28.01 Direct F1
holding CGON Employee Stock Option (Right to Buy) 05 Aug 2025 Common Stock 9.36K $36.63 Direct F2
holding CGON Employee Stock Option (Right to Buy) 05 Aug 2025 Common Stock 21.6K $20.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option vested on May 15, 2025, the first anniversary of the vesting commencement date, and the remaining shares vest in equal monthly installments over the next 36 months, subject to the Reporting Person's continuous service to the Issuer through each vesting date
F2 1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F3 1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Remarks:

Interim Principal Financial and Accounting Officer